Healthcare professional disclaimer: This page is for informational purposes only and is not medical advice. For personal dosing, missed-dose instructions, or side effect concerns, consult a licensed clinician.
Quick answer
FDA labeling for tirzepatide reports an elimination half-life of approximately 5 days. With once-weekly injections, that often shows up as a weekly “peak then taper” rhythm.
What half-life means (practically)
- It describes a gradual decline in the amount of drug in the body.
- With weekly dosing, doses overlap (accumulation), then levels stabilize after a few weeks of consistency.
- Many real-world factors can change how you feel week-to-week (sleep, diet, stress, other meds), so don’t over-attribute everything to pharmacokinetics.
Missed or late doses: the timing logic (not advice)
If a dose is late, you’re usually injecting from a lower point on your weekly curve. Longer gaps allow more clearance. What to do depends on the product instructions and your clinician’s plan.
How to track your pattern (and bring it to your clinician)
- Injection date/time and dose
- Appetite score (same scale each week)
- Common side effects (nausea, constipation, fatigue) and severity
Track your weekly rhythm in Jabbit
Log injections + symptoms, then review the day-by-day pattern before appointments.
Get Jabbit on the App StoreSources
- FDA label (Mounjaro, tirzepatide): accessdata.fda.gov (PDF)
- FDA label (Zepbound, tirzepatide): accessdata.fda.gov (PDF)